S100A5, E.coli Rec. Prot.
- Known as:
- S100A5, E.coli Rec. Prot.
- Catalog number:
- rd172212100
- Product Quantity:
- EUR
- Category:
- -
- Supplier:
- Biovendor
- Gene target:
- S100A5 .coli Rec. Prot.
Related genes to: S100A5, E.coli Rec. Prot.
- Gene:
- FCN2 NIH gene
- Name:
- ficolin 2
- Previous symbol:
- -
- Synonyms:
- P35, FCNL, EBP-37, ficolin-2
- Chromosome:
- 9q34.3
- Locus Type:
- gene with protein product
- Date approved:
- 1996-07-11
- Date modifiied:
- 2016-10-05
- Gene:
- PRR5 NIH gene
- Name:
- proline rich 5
- Previous symbol:
- -
- Synonyms:
- PP610, FLJ20185k, Protor-1
- Chromosome:
- 22q13.31
- Locus Type:
- gene with protein product
- Date approved:
- 2006-03-16
- Date modifiied:
- 2016-10-05
- Gene:
- REC8 NIH gene
- Name:
- REC8 meiotic recombination protein
- Previous symbol:
- REC8L1
- Synonyms:
- Rec8p, kleisin-alpha
- Chromosome:
- 14q12
- Locus Type:
- gene with protein product
- Date approved:
- 2003-09-29
- Date modifiied:
- 2016-01-15
- Gene:
- RECQL NIH gene
- Name:
- RecQ like helicase
- Previous symbol:
- -
- Synonyms:
- RecQ1, RecQL1
- Chromosome:
- 12p12.1
- Locus Type:
- gene with protein product
- Date approved:
- 1994-03-25
- Date modifiied:
- 2016-02-05
- Gene:
- RECQL4 NIH gene
- Name:
- RecQ like helicase 4
- Previous symbol:
- -
- Synonyms:
- RecQ4
- Chromosome:
- 8q24.3
- Locus Type:
- gene with protein product
- Date approved:
- 1999-05-06
- Date modifiied:
- 2019-04-23
Related products to: S100A5, E.coli Rec. Prot.
(Des_Met0)_rec TGF a (human) (expressed in E.coli) Salt _ Binding _ Synonym SumFormula(Des_Met0)_rec TGF a (human) (expressed in E.coli) Salt _ Binding _ Synonym SumFormula([125I]-Tyr)-rec EGF (human)([125I]-Tyr)-rec EGF (human)([125I]-Tyr)-rec EGF (human), CE-marked, Liquid([125I]-Tyr)-rec EGF (human), CE-marked, Liquid([125I]-Tyr)-rec EGF (human), CE-marked, Liquid([125I]-Tyr)-rec EGF (human), CE-marked, Lyophilized([125I]-Tyr)-rec EGF (human), CE-marked, Lyophilized([125I]-Tyr)-rec EGF (human), CE-marked, Lyophilized([125I]-Tyr)-rec EGF (human)CE-markedLiquid([125I]-Tyr)-rec EGF (human)CE-markedLyophilized([125I]-Tyr)-rec IGF-I (human)([125I]-Tyr)-rec IGF-I (human)([125I]-Tyr)-rec IGF-I (human), CE-marked, Liquid Related articles to: S100A5, E.coli Rec. Prot.
- In mammals, odors are encoded by a combinatorial code determined by the pattern of responses across hundreds of odorant receptors expressed monogenically and monoallelically in olfactory sensory neurons. The compositions of these receptor response patterns are largely unknown and overlap between them has yet to be explored. Activity-dependent reporter gene expression in freely behaving S100a5-tauGFP mice allowed capture of activated olfactory sensory neurons and identified 168 receptors responsive to moderate concentrations of 1 or more of 12 aliphatic (5 to 8 carbons) ketones, alcohols, and carboxylic acids. These 12 response patterns are remarkably different, with only 19% of the receptors responding to more than 1 of these odorants. This distinctiveness corresponds with the ease of discrimination of these odorants and may help maintain perceptual constancy in the face of response pattern variability, such as across odorant concentrations. This set of 168 receptors is not specific to aliphatic odorants but instead has 16% overlap with the receptors responsive to 7 odors tested previously in vivo, consistent with a receptor repertoire evolved to produce combinatorial codes. Aliphatic odorant response pattern similarity depends more upon odorant functional group than carbon chain length but the impact of chain length increases with the number of carbons. The response patterns to these aliphatic odorants are mostly composed of unrelated receptors, except some patterns contain minor subsets of closely related receptors. These findings argue that the major selective forces driving OR evolution are expansion of the odorant receptor gene family and the production of distinct response patterns. - Source: PubMed
de March Claire ABreheny PatrickTitlow William BMatsunami HiroakiMcClintock Timothy S - The S100 family contains more than 20 Ca2+-binding proteins that participate in numerous cellular biological processes. However, the prognostic value of individual S100s in hepatocellular carcinoma (HCC) remains unclear. Therefore, we comprehensively assessed the prognostic value of S100s in HCC. - Source: PubMed
Wan RenruiTan ZhenhuaQian HaiLi PengZhang JianZhu XiaofengXie PingRen Lingyan - Hair is one of the common pieces of evidence at crime scenes, with abundant mitochondrial DNA but limited nuclear DNA in its shaft. It also helps to narrow the investigation scope to maternal lineage but fails to provide unique individual information. We assumed that RNA in hair shafts would be an alternative resource used to perform human identification based on the facts that (1) RNA retains the polymorphic information; (2) the multi-copy of RNA in a cell resists degradation as compared to the one-copy of nuclear DNA. In this study, we explored the potential of RNA polymorphism in hair shafts for forensic individual identification. A SNaPshot typing system was constructed using 18 SNPs located on 11 genes (ABCA13, AHNAK, EXPH5, KMT2D, KRT35, PPP1R15A, RBM33, S100A5, TBC1D4, TMC5, TRPV2). The RNA typing system was evaluated for sensitivity, species specificity, and feasibility for aged hair samples. Hair samples from a Shanxi population in China were used for the population study of the system. The detection limit of the assay was 2 ng RNA. The CDP of these 11 genes was 0.999969 in the Shanxi population. We also identified the concordance of the RNA and DNA typing results. In summary, we developed an RNA typing method to perform human identification from hair shafts, which performed as accurately as nuclear DNA typing. Our method provides a potential basis for solving the human identification problem from hair shafts, as well as other biological materials that lack nuclear DNA. - Source: PubMed
Publication date: 2023/08/09
Liu YaoFan JiajiaZhang MingmingLiu ZidongWang JiaqiLiu JindingLi ZeqinYang FanZhang Gengqian - Although immune checkpoint blockade (ICB) therapies have been approved for bladder cancer (BLCA), only a minority of patients respond to these therapies, and there is an urgent need to explore combined therapies. Systematic multi-omics analysis identified S100A5 as a novel immunosuppressive target for BLCA. The expression of S100A5 in malignant cells inhibited CD8 T cell recruitment by decreasing pro-inflammatory chemokine secretion. Furthermore, S100A5 attenuated effector T cell killing of cancer cells by inhibiting CD8 T cell proliferation and cytotoxicity. In addition, S100A5 acted as an oncogene, thereby promoting tumor proliferation and invasion. Targeting S100A5 synergized with the efficacy of anti-PD-1 treatment by enhancing infiltration and cytotoxicity of CD8 T cells in vivo. Clinically, there was a spatially exclusive relationship between S100A5 tumor cells and CD8 T cells in tissue microarrays. Moreover, S100A5 negatively correlated with immunotherapy efficacy in our real-world and several public immunotherapy cohorts. In summary, S100A5 shapes a non-inflamed tumor microenvironment in BLCA by inhibiting the secretion of pro-inflammatory chemokines and the recruitment and cytotoxicity of CD8 T cells. Targeting S100A5 converts cold tumors into hot tumors, thus enhancing the efficacy of ICB therapy in BLCA. - Source: PubMed
Publication date: 2023/07/06
Li HuihuangChen JinboLi ZhenghaoChen MinfengOu ZhenyuMo MiaoWang RuizheTong ShiyuLiu PeihuaCai ZhiyongZhang ChunyuLiu ZhiDeng DingshanLiu JinhuiCheng ChunliangHu JiaoZu Xiongbing - Age-related macular degeneration (AMD) is a leading cause of blindness in the industrialised world and is projected to affect >280 million people worldwide by 2040. Aiming to identify causal factors and potential therapeutic targets for this common condition, we designed and undertook a phenome-wide Mendelian randomisation (MR) study. - Source: PubMed
Publication date: 2023/01/27
Julian Thomas HCooper-Knock JohnathanMacGregor StuartGuo HuiAslam TariqSanderson EleanorBlack Graeme C MSergouniotis Panagiotis I